Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Account Payables (2016 - 2019)

Historic Change in Account Payables for Sunshine Biopharma (SBFM) over the last 8 years, with Q4 2019 value amounting to $33797.0.

  • Sunshine Biopharma's Change in Account Payables fell 4957.18% to $33797.0 in Q4 2019 from the same period last year, while for Dec 2019 it was -$18692.0, marking a year-over-year decrease of 13032.99%. This contributed to the annual value of -$35012.0 for FY2020, which is 8731.01% down from last year.
  • Latest data reveals that Sunshine Biopharma reported Change in Account Payables of $33797.0 as of Q4 2019, which was down 4957.18% from -$21040.0 recorded in Q3 2019.
  • In the past 5 years, Sunshine Biopharma's Change in Account Payables ranged from a high of $342944.0 in Q2 2017 and a low of -$359099.0 during Q3 2017
  • Moreover, its 5-year median value for Change in Account Payables was -$122.0 (2018), whereas its average is -$2002.4.
  • As far as peak fluctuations go, Sunshine Biopharma's Change in Account Payables crashed by 658713.45% in 2018, and later surged by 1811393.44% in 2019.
  • Over the past 5 years, Sunshine Biopharma's Change in Account Payables (Quarter) stood at $11830.0 in 2015, then skyrocketed by 134.99% to $27799.0 in 2016, then plummeted by 72.96% to $7518.0 in 2017, then surged by 791.46% to $67020.0 in 2018, then crashed by 49.57% to $33797.0 in 2019.
  • Its Change in Account Payables stands at $33797.0 for Q4 2019, versus -$21040.0 for Q3 2019 and $21977.0 for Q2 2019.